09-05-2019 07:30 CET Three-month interim report (Q1) 2019
21-03-2019 16:57 CET Grant of share options and performance shares to members of the Board of Management and key employees
13-03-2019 17:14 CET Annual General Meeting in ALK-Abelló A/S held on 13 March 2019
14-02-2019 14:00 CET Annual General Meeting in ALK-Abelló A/S on 13 March 2019
07-02-2019 07:32 CET ALK releases its annual report 2018
15-01-2019 14:21 CET Large-scale paediatric SLIT-tablet trial meets primary endpoint, confirming potential in children
15-01-2019 09:58 CET ALK's Board of Directors to nominate Vincent Warnery as new member of the Board
11-01-2019 16:44 CET ALK appoints new Head of Product Supply
20-12-2018 13:58 CET ALK – Financial calendar for the 2019 financial year
14-12-2018 14:33 CET ALK upgrades its full-year financial outlook due to accelerated sales
09-11-2018 07:33 CET Nine-month interim report (Q3) 2018
22-08-2018 16:17 CET ALK submits registration application for tree SLIT-tablet in Europe
15-08-2018 07:37 CET Six-month interim report (Q2) 2018
04-05-2018 07:35 CET Three-month interim report (Q1) 2018
20-03-2018 16:19 CET Grant of share options and performance shares to members of the Board of Management and key employees
16-03-2018 10:54 CET Articles of Association
12-03-2018 17:22 CET Annual General Meeting in ALK-Abelló A/S held on 12 March 2018
02-03-2018 16:49 CET Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
16-02-2018 07:00 CET ALK’s partner, Torii, gains paediatric approval for the house dust mite SLIT-tablet in Japan
13-02-2018 13:55 CET Annual General Meeting in ALK-Abelló A/S on 12 March 2018